Seòmar agus comataidhean

The primary objective of the booster programme is to maintain protection against severe COVID-19 disease, specifically hospitalization and deaths, over winter 2021-22, and is aimed at maintaining protection in those most vulnerable and to protect the NHS. The autumn/winter vaccination programme also includes the biggest ever flu vaccination programme.

The Joint Committee on Vaccination and Immunisation (JCVI) is clear that both of these programmes are important for individual and public health. So, wherever possible, eligible people will be offered COVID-19 and influenza vaccines together.

Booster vaccines will be offered to the same groups who were prioritized at the beginning of the COVID-19 vaccination programme in winter and spring 2020-21, and JCVI have advised that at least 6 months should have passed since a second dose before a booster is administered, however there is some flexibility to offer a booster vaccination to the most vulnerable groups after five months.

The Autumn/Winter vaccination programme continues to roll out in line with advice from the JCVI. The JCVI priority groups are based on either vulnerability to COVID-19, or on interacting with, and therefore possibly spreading to, people who are vulnerable to COVID-19. When someone received their invitation will depend on a number of personal circumstances.

Decisions to prioritise one population group over another are not taken lightly, nor are they straightforward. That is why our prioritisation decisions have been, and will continue to be, guided by the independent expert advice from the JCVI.

Our approach to service development and staff training is informed by UK-wide clinical guidance developed by the National Institute for Health and Care Excellence (NICE), the Scottish Intercollegiate Guidelines Network (SIGN) and the Royal College of General Practitioners (RCGP) and is focussed on supporting NHS Boards to develop tailored models of care appropriate for the needs of their populations.

Scottish Government Officials and Clinical Advisors continue to meet with colleagues across the UK home nations on a regular basis, in order to support the sharing of relevant practice developments as they continue to emerge.

It is important that new systems of care supported by a limited and emerging evidence base are properly evaluated within research conditions in order to deliver quality, cost-effective interventions that provide meaningful benefit for patients.

Our approach to service development and staff training is informed by UK-wide clinical guidance developed by the National Institute for Health and Care Excellence (NICE), the Scottish Intercollegiate Guidelines Network (SIGN) and the Royal College of General Practitioners (RCGP) and is focussed on supporting NHS Boards to develop tailored models of care appropriate for the needs of their populations.

Scottish Government Officials and Clinical Advisors continue to meet with colleagues across the UK home nations on a regular basis, in order to support the sharing of relevant practice developments as they continue to emerge.

It is important that new systems of care supported by a limited and emerging evidence base are properly evaluated within research conditions in order to deliver quality, cost-effective interventions that provide meaningful benefit for patients.

The national pancreatic cancer audit is an NHS England initiative and Scotland participates in UK audits (Scottish Cancer Registry data is provided by Public Health Scotland). The Scottish HepatoPancreatoBiliary Network (SHPBN) has reported HepatoPancreatoBiliary (HPB) cancer audits annually since 2010. The 2013-2019 audits are based on quality performance indicators, including some specific to pancreatic cancer. The annual audit reports are available on the SHPBN website. The 2020 audit report is currently in progress.

Through the National Cancer Plan we have placed an emphasis on the less survivable cancers, including pancreatic, and improving their outcomes. We have provided funding and are working with the SHPBN to redesign pancreatic and liver pathways.

Our COVID Status Certification scheme is a necessary, proportionate, and a limited measure targeted towards activities that are a higher risk. This is an alternative to the potential closure of higher risk venues.

We have taken an equality and human rights approach; and have considered how the scheme may impact individuals and communities. This includes, considering the scheme’s compatibility with the Convention Rights identified in the Human Rights Act 1998 and with the requirements of the Equality Act 2010. Other requirements, such as the rights enshrined in the United Nations Convention on the Rights of the Child (UNCRC) have also been taken into account.

In developing the scheme, ministers and officials have engaged pro-actively with a wide range of stakeholders, including but not limited to, those representing human rights, children’s rights, and each of the protected characteristics in the Equality Act. Stakeholder views and evidence have been reflected in our published impact assessments.

Our decisions are taken, and reviewed on the latest data and clinical evidence . Our review process includes consideration of the impact assessments, such as Equality Impact Assessment (EQIA) and Children’s Rights and Wellbeing Impact Assessment .

I refer the member to the answer to question S6W-03618 on 8 November 2021. All answers to written parliamentary questions are available on the Parliament's website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers

During 2020-21 the percentage of total NHS procedures carried out by non NHS-providers was 0.6%. Non-NHS provider figures relate to NHS patients treated in non-NHS locations such as private hospitals, hospices, nursing homes, care homes, etc.

The impact of addressing the COVID-19 pandemic has meant that many health and social care services had to be suspended or reduced in scope and scale. This has affected almost all aspects of NHS Care. As a result, this regrettably means there are many people who are waiting longer for the care they need. Addressing the backlog of care, while continuing to meet the ongoing urgent health and care needs of the country, is a priority for this Government.

The Scottish Government remains fully committed to a publicly funded National health service that is accessible to all of the people of Scotland. That is why the First Minster launched the NHS Recovery Plan on the 25 August which sets out our objectives for tackling the Covid-19 related backlogs of care and putting the NHS on a sustainable path for the future. The plan is backed by more than £1 billion of investment over the next five years of which over £400 million will support nine National Treatment Centres (NTC) – the first of which opened at the Golden Jubilee November 2020.

Vaccination appointments including boosters, are scheduled based on the cohorts defined by the Joint Committee on Vaccination and Immunisation (JCVI) and from the files submitted by Health Boards. These are in priority order based on risk to the individual, rather than postcode alignment. For example, a married couple in the same house, one 68 years old and one 71 years old, would see them placed in different JCVI risk cohorts, therefore the 71 year old would be scheduled before the 68 year old, and their appointments may be days or weeks apart.

Individual cases can be considered by the Health Board if a priority, and support arranged.

The Scottish Government provided support and funding to develop British Standard for evacuation alert systems and engaged with the National Fire Chiefs Council, Scottish Fire and Rescue Service and the UK Government in that work.

The National Fire Chiefs Council and UK Government comprise the Stay Put Technical Steering Group which is overseeing research on means of escape from a design, management and operational perspective. The Scottish Government and Scottish Fire and Rescue Service awaits the research findings, as they are key to informing any potential improvements and future approaches.

Public Health Scotland have confirmed that a hot debrief is guidance and not mandatory. The Incident Management Team therefore did not completed a hot debrief relating to the COVID-19 outbreak at the Nike Conference. Public Health Scotland have, however, published the Incident Management Team Report relating to this event. Learning around Covid-19 is a continuous process and findings such as this report inform the wider response to the pandemic in Scotland.